Essential (hemorrhagic) thrombocythemia BILLABLE | ICD-10 from 2011 - 2016 D47.3 is a billable ICD code used to specify a diagnosis of essential (hemorrhagic) thrombocythemia. A 'billable code' is detailed enough to be used to specify a medical diagnosis. The ICD code D473 is used to code Thrombocytosis
ICD-10 code D47.3 for Essential (hemorrhagic) thrombocythemia is a medical classification as listed by WHO under the range - Neoplasms . Subscribe to Codify and get the code details in a flash. Request a Demo 14 Day Free Trial Buy Now Official Long Descriptor Essential (hemorrhagic) thrombocythemia Essential thrombocytosis
Oct 01, 2021 · ICD-10-CM Code. D47.3. D47.3 is a valid billable ICD-10 diagnosis code for Essential (hemorrhagic) thrombocythemia . It is found in the 2022 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2021 - Sep 30, 2022 . See also, ICD-10 Table of Neoplasms.
Oct 01, 2021 · The 2022 edition of ICD-10-CM D75.839 became effective on October 1, 2021. This is the American ICD-10-CM version of D75.839 - other international versions of ICD-10 D75.839 may differ. Applicable To Thrombocythemia NOS Thrombocytosis NOS The following code (s) above D75.839 contain annotation back-references that may be applicable to D75.839 :
Essential thrombocythemia (throm-boe-sie-THEE-me-uh) is an uncommon disorder in which your body produces too many platelets. Platelets are the part of your blood that sticks together to form clots. This condition may cause you to feel fatigued and lightheaded and to experience headaches and vision changes.Oct 21, 2020
Thrombocythemia refers to a high platelet count that is not caused by another health condition. This condition is sometimes called primary or essential thrombocythemia. Thrombocytosis refers to a high platelet count caused by another disease or condition.Mar 24, 2022
Cause. Essential thrombocythemia may be caused by acquiring somatic mutations (not inherited mutations ) in any of several genes , including the JAK2 gene (most frequently) and CALR gene. In rare cases, the disease is caused by mutations in the MPL, THPO, or TET2 gene.
Thrombocythemia is a disease in which your bone marrow makes too many platelets. Platelets are blood cell fragments that help with blood clotting. Having too many platelets makes it hard for your blood to clot normally. This can cause too much clotting, or not enough clotting.
The diagnosis of Bernard-Soulier syndrome is made by a combination of blood testing to reveal whether platelets are at abnormally low levels (thrombocytopenia), microscopic examination to determine the presence of abnormally large platelets and irregularly shaped platelets, and a test called 'flow cytometry, which is ...
Essential thrombocythaemia (ET) is a rare blood cancer that causes a high number of blood cells called platelets to form. These cells are involved in blood clotting. It is one of a group of conditions called myeloproliferative neoplasms or myeloproliferative disorders.
Although altered lymphocyte and immune functions have been known in patients with PTSD, essential thrombocytosis is a rare phenomenon. This report has introduced an individual exposure to traumatic stress which has currently lower social support with higher rates of post-traumatic stress and associated disorders.
Conclusions Essential thrombocythemia is a benign disease of older persons. Chinese patients have a low risk of bleeding, and prior myelofibrosis is a major risk factor for evolution to acute myeloid leukemia. Leukemic transformation with hydroxyurea therapy alone is rare and warrants further prospective studies.
If your blood count is above 450,000 platelets per microliter of blood, your doctor will look for an underlying condition. He or she will rule out all other causes of high platelet counts to confirm a diagnosis of essential thrombocythemia.Oct 21, 2020
Myeloproliferative neoplasms are a group of diseases in which the bone marrow makes too many red blood cells, white blood cells, or platelets. Normally, the bone marrow makes blood stem cells (immature cells) that become mature blood cells over time. Enlarge.Mar 4, 2022
Idiopathic thrombocytopenic purpura is a blood disorder characterized by an abnormal decrease in the number of platelets in the blood. A decrease in platelets can result in easy bruising, bleeding gums, and internal bleeding. ITP may be acute and resolve in less than 6 months, or chronic and last longer than 6 months.
Essential Thrombocythemia (ET) Is a rare blood disease in which the bone marrow produces too many platelets. High numbers of platelets may lead to a thrombus, a blood clot that forms in a blood vessel. This can cause serious health problems such as a stroke, heart attack or pulmonary embolism.
Thrombocytosis (or thrombocythemia) is the presence of high platelet counts in the blood, and can be either primary (also termed essential and caused by a myeloproliferative disease) or reactive (also termed secondary). Although often symptomless (particularly when it is a secondary reaction), it can predispose to thrombosis in some patients.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
DRG Group #814-816 - Reticuloendothelial and immunity disorders with MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code D47.3. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code D47.3 and a single ICD9 code, 238.71 is an approximate match for comparison and conversion purposes.